{
    "eid": "2-s2.0-85086022387",
    "title": "The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones",
    "cover-date": "2020-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Clinical Psychology",
            "@code": "3203",
            "@abbrev": "PSYC"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Antioxidants",
        "Anxiety",
        "Biomarkers",
        "Depression",
        "Inflammation",
        "Neuro-immune",
        "Oxidative stress",
        "Premenstrual syndrome"
    ],
    "authors": [
        "Chutima Roomruangwong",
        "Andressa Keiko Matsumoto",
        "Ana Paula Michelin",
        "Laura de Oliveira Seme\u00e3o",
        "Jo\u00e3o Victor de Lima Pedr\u00e3o",
        "Estefania G. Moreira",
        "Sunee Sirivichayakul",
        "Andre Carvalho",
        "Decio S. Barbosa",
        "Michael Maes"
    ],
    "citedby-count": 12,
    "ref-count": 74,
    "ref-list": [
        "Premenstrual syndrome: a mini review",
        "Premenstrual symptoms \u2013 severity, duration and typology: an international cross-sectional study",
        "Premenstrual syndrome health-related quality of life and psychiatric comorbidity in a clinical adolescent sample: a cross-sectional study",
        "Bipolar disorder and Premenstrual Syndrome or Premenstrual Dysphoric Disorder comorbidity: a systematic review",
        "Prevalence and factors associated with Premenstrual Dysphoric Disorder: a community sample of young adult women",
        "Daily Record of Severity of Problems (DRSP): reliability and validity",
        "Premenstrual syndrome and premenstrual dysphoric disorder",
        "Premenstrual syndrome and premenstrual dysphoric disorder",
        "Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China",
        "Guidelines for Women's Health Care: A Resource Manual",
        "Lowered plasma steady-state levels of progesterone combined with declining progesterone levels during the luteal phase predict Peri-menstrual syndrome and its major subdomains",
        "The uterine-chemokine-brain axis: menstrual cycle-associated symptoms (MCAS) are in part mediated by CCL2, CCL5, CCL11, CXCL8 and CXCL10",
        "Inflammation, leukocytes and menstruation",
        "Implantation, menstruation and inflammation",
        "Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study",
        "Normal menstrual cycle",
        "Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation",
        "Female hormones act as natural antioxidants\u2013a survey of our research",
        "Estrogen and estrogen receptors in cardiovascular oxidative stress",
        "Changes in activity of superoxide dismutase in the human endometrium throughout the menstrual cycle and in early pregnancy",
        "NF-kappaB activation by reactive oxygen species: fifteen years later",
        "Withdrawal of ovarian steroids stimulates prostaglandin F2alpha production through nuclear factor-kappaB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation",
        "Chronic Inflammation and Premenstrual Syndrome: A Missing Link Found?",
        "The Association of Inflammation with Premenstrual Symptoms",
        "Menstruation, inflammation and comorbidities: implications for woman health",
        "Inflammation and endometrial bleeding",
        "Menstrual cycle symptoms are associated with changes in low-grade inflammation",
        "Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women",
        "The menstrual cycle may not be limited to the endometrium but also may impact gut permeability",
        "Oxidative & nitrosative stress in depression: why so much stress?",
        "A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness",
        "Generalized anxiety disorder (GAD) and comorbid major depression with GAD are characterized by enhanced nitro-oxidative stress, increased lipid peroxidation, and lowered lipid-associated antioxidant defenses",
        "Major differences in Neurooxidative and Neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder",
        "Is a diagnostic blood test for chronic fatigue syndrome on the horizon?",
        "Mechanisms explaining muscle fatigue and muscle pain in patients with Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a review of recent findings",
        "Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome",
        "Oxidant/antioxidant status in premenstrual syndrome",
        "Serum oxidative stress, visfatin and apelin in healthy women and those with premenstrual syndrome",
        "Novel aspects of the endocrinology of the menstrual cycle",
        "The normal menstrual cycle in women",
        "Physiology of the menstrual cycle",
        "Improved detection of advanced oxidation protein products in plasma. Clinica chimica acta",
        "Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle",
        "Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy",
        "Semiautomated measurement of nitrate in biological fluids",
        "Oxidative stress in blood of HIV infected patients",
        "Measurement of protein thiol groups and glutathione in plasma",
        "The analytical performance of a microplatemethod for total sulfhydryl measurement in biological samples",
        "In schizophrenia, PON1 Q192R genotypes and/or lowered Paraoxonase 1 (PON1) enzymatic activity are significantly associated with the deficit syndrome, negative symptoms, formal thought disorders, psychomotor retardation, excitation and increased IgA levels to gram-negative microbiota",
        "Determination of paraoxonase 1 status without the use of toxic organophosphate substrates",
        "Controlling the false discovery rate: a practical and powerful approach to multiple testing",
        "A Comprehensive Point-of-Care Guide for over 600 Lab Tests",
        "Mosby's Manual of Diagnostic and Laboratory Tests",
        "The blood-uterine lumen barrier and exchange between extracellular fluids",
        "A comparison of transcriptomic profiles in endometrium during window of implantation between women with unexplained recurrent implantation failure and recurrent miscarriage",
        "The effect of estradiol on the production and secretion of complement component 3 by the rat uterus and surgically induced endometriotic tissue",
        "Localization of the expression of complement component 3 in the human endometrium by in situ hybridization",
        "Hormonal regulation of complement components and receptors throughout the menstrual cycle",
        "Antioxidant status and lipid peroxidation in premenstrual syndrome: a preliminary study",
        "Malon dialdehyde, nitrite and adrenomedullin levels in patients with premenstrual syndrome",
        "Natural regulatory IgM-mediated autoimmune responses directed against malondialdehyde regulate oxidative and nitrosative pathways and coupled with IgM responses to nitroso adducts attenuate depressive and physiosomatic symptoms at the end of term pregnancy",
        "In schizophrenia, deficits in natural IgM isotype antibodies including those directed to malondialdehyde and Azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome",
        "Total oxidant\u2013antioxidant and paraoxonase-1 levels in premenstrual dysphoric disorder: a follow-up study",
        "Why should psychiatrists and neuroscientists worry about Paraoxonase 1?",
        "Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet",
        "Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs",
        "Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder",
        "Lowered PON1 activities are strongly associated with depression and bipolar disorder, recurrence of (hypo)mania and depression, increased disability and lowered quality of life",
        "Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders",
        "The role of PON-1, GR, IL-18, and OxLDL in depression with and without posttraumatic stress disorder",
        "Progesterone treatment reduces neuroinflammation, oxidative stress and brain damage and improves long-term outcomes in a rat model of repeated mild traumatic brain injury",
        "The effect of progesterone on systemic inflammation and oxidative stress in the rat model of sepsis",
        "Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen",
        "Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Londrina",
            "@id": "60027866",
            "affilname": "Universidade Estadual de Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027866",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "Ratchadaphiseksomphot Fund",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}